Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomes.
about
Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomes.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Phase 1 trial of vamorolone, a ...... bridged to clinical outcomes.
@en
Phase 1 trial of vamorolone, a ...... bridged to clinical outcomes.
@nl
type
label
Phase 1 trial of vamorolone, a ...... bridged to clinical outcomes.
@en
Phase 1 trial of vamorolone, a ...... bridged to clinical outcomes.
@nl
prefLabel
Phase 1 trial of vamorolone, a ...... bridged to clinical outcomes.
@en
Phase 1 trial of vamorolone, a ...... bridged to clinical outcomes.
@nl
P2093
P2860
P1433
P1476
Phase 1 trial of vamorolone, a ...... bridged to clinical outcomes.
@en
P2093
Daniel Dickerson
Eric P Hoffman
Heather Gordish-Dressman
Jesse M Damsker
John M McCall
Maxime A Siegler
Miroslav Backonja
Valerie Riddle
William G Kramer
P2860
P356
10.1016/J.STEROIDS.2018.02.010
P577
2018-03-07T00:00:00Z